Miguel Górgolas Hernández-Mora

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Chloe Orkin, Keikawus Arastéh, Miguel Górgolas Hernández-Mora et al. · New England Journal of Medicine · 2020 · 464 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Giuliano Rizzardini, Edgar T. Overton, Chloe Orkin et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 149 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Jesús Rodríguez‐Baño, Jerónimo Pachón, Jordi Carratalà et al. · Clinical Microbiology and Infection · 2020 · 127 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, Alberto M. Borobia, Antonio J. Carcas et al. · The Lancet Infectious Diseases · 2021 · 102 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +13

COVID-19 Outcomes in 4712 consecutively confirmed SARS-CoV2 cases in the city of Madrid

Sarah Heili-Frades, Pablo Mínguez, Tomás Prieto-Rumeau et al. · medRxiv · 2020 · 20 citations · Full text

Medicine, Infectious Diseases, Pharmacology +12